Header Logo

Connection

GUILLERMO GARCIA-MANERO to Cytochrome P-450 CYP3A Inhibitors

Back to Details
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Cytochrome P-450 CYP3A Inhibitors.
GUILLERMO GARCIA-MANERO
Connection Strength
0.039
Cytochrome P-450 CYP3A Inhibitors
  1. Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. Am J Hematol. 2018 03; 93(3):401-407.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.